Cargando…
KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy
BACKGROUND: This study was carried out to evaluate the prognostic value of KIBRA in breast cancer. METHODS: This retrospective study included breast cancer patients who sought the services of the immunohistochemistry laboratory of our unit from 2006 to 2015. Tissue microarrays were constructed and i...
Autores principales: | Mudduwa, Lakmini, Peiris, Harshini, Gunasekara, Shania, Abeysiriwardhana, Deepthika, Liyanage, Nimsha, Rayala, Suresh K., Liyanage, Thusharie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968668/ https://www.ncbi.nlm.nih.gov/pubmed/29793439 http://dx.doi.org/10.1186/s12885-018-4491-6 |
Ejemplares similares
-
Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers
por: Mudduwa, Lakmini, et al.
Publicado: (2017) -
Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?
por: Mudduwa, Lakmini KB, et al.
Publicado: (2018) -
KIBRA attains oncogenic activity by repressing RASSF1A
por: , Anuj, et al.
Publicado: (2017) -
Validity of St Gallen risk categories in prognostication of breast cancer patients in Southern Sri Lanka
por: Peiris, Harshini, et al.
Publicado: (2018) -
Barleria prionitis L. extracts ameliorate doxorubicin-induced acute kidney injury via modulation of oxidative stress, inflammation, and apoptosis
por: Amarasiri, Sachinthi S., et al.
Publicado: (2023)